Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nicholls

Showing results (1361-1370 of 1,396) with videos related to

Pageof 140
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2017
Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR studyRishi Puri, Imanol Otaegui, Manel Sabaté, et al.
American Heart Journal|June 17, 2018
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
The New England Journal of Medicine|May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular DiseaseA Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Circulation|May 19, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV TrialBrian A Bergmark, Erin A Bohula, Nicholas A Marston, et al.
European Heart Journal|September 2, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trialC Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, et al.
The Lancet. Digital Health|March 26, 2022
Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre studyAndrew Lin, Nipun Manral, Priscilla McElhinney, et al.
The New England Journal of Medicine|March 6, 2023
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant PatientsSteven E Nissen, A Michael Lincoff, Danielle Brennan, et al.
JAMA Cardiology|March 12, 2018
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical TrialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
The New England Journal of Medicine|November 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis RiskNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Pageof 140

Showing results (1361-1370 of 1,396) with videos related to

Sort By:
Pageof 140
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2017
Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR studyRishi Puri, Imanol Otaegui, Manel Sabaté, et al.
American Heart Journal|June 17, 2018
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
The New England Journal of Medicine|May 18, 2017
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular DiseaseA Michael Lincoff, Stephen J Nicholls, Jeffrey S Riesmeyer, et al.
Circulation|May 19, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV TrialBrian A Bergmark, Erin A Bohula, Nicholas A Marston, et al.
European Heart Journal|September 2, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trialC Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, et al.
The Lancet. Digital Health|March 26, 2022
Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre studyAndrew Lin, Nipun Manral, Priscilla McElhinney, et al.
The New England Journal of Medicine|March 6, 2023
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant PatientsSteven E Nissen, A Michael Lincoff, Danielle Brennan, et al.
JAMA Cardiology|March 12, 2018
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical TrialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
The New England Journal of Medicine|November 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis RiskNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Pageof 140